Endonovo Therapeutics Inc. (ENDV) Announces Nationwide Strategy as it Promotes Non-Drug Alternative to Opioid Addiction Crisis
Endonovo Therapeutics is developing bioelectronic devices that target patient pain, inflammation and wound recovery The company intends to get its flagship SofPulse device into 600 hospitals within the next 18 months as part of its bid to reduce post-operative drug dependence Drug dependence is regarded as a major contributor to a global opioid epidemic that has driven advocacy for less harmful pain drugs, increased governmental funding and new sentencing protocols for drug-related crimes The U.S. government has spent $2.4 billion during the past two years on addiction intervention amid statistics showing pain-killer death totals in the tens of thousands each…
